These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 35065256)
1. Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination. Amiya S; Fujimoto J; Matsumoto K; Yamamoto M; Yamamoto Y; Yoneda M; Kuge T; Miyake K; Shiroyama T; Hirata H; Takeda Y; Kumanogoh A Int J Infect Dis; 2022 Mar; 116():255-257. PubMed ID: 35065256 [TBL] [Abstract][Full Text] [Related]
2. Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination. Sakayori M; Hagiwara E; Baba T; Kitamura H; Sekine A; Ikeda S; Tabata E; Yamada S; Fujimoto K; Ogura T J Infect Chemother; 2023 Jan; 29(1):105-108. PubMed ID: 36113847 [TBL] [Abstract][Full Text] [Related]
3. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045 [TBL] [Abstract][Full Text] [Related]
4. Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination: A Case Series. Ishioka Y; Makiguchi T; Itoga M; Tanaka H; Taima K; Goto S; Tasaka S Chest; 2022 Dec; 162(6):e311-e316. PubMed ID: 36494131 [TBL] [Abstract][Full Text] [Related]
5. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease. Beckley M; Olson AK; Portman MA JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521 [TBL] [Abstract][Full Text] [Related]
6. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study. Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759 [TBL] [Abstract][Full Text] [Related]
7. [Severe thrombocytopenia after COVID-19 mRNA vaccination]. Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337 [TBL] [Abstract][Full Text] [Related]
8. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Maeda M; Isawa T; Tada N Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122 [No Abstract] [Full Text] [Related]
9. COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia. Kitayama T; Kitamura H; Hagiwara E; Higa K; Okabayashi H; Oda T; Baba T; Komatsu S; Iwasawa T; Ogura T Intern Med; 2020 Dec; 59(24):3207-3211. PubMed ID: 33087668 [TBL] [Abstract][Full Text] [Related]
10. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review. Wang Y; Yang L; Xu G J Epidemiol Glob Health; 2023 Dec; 13(4):615-636. PubMed ID: 37870719 [TBL] [Abstract][Full Text] [Related]
11. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459 [No Abstract] [Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
14. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728 [TBL] [Abstract][Full Text] [Related]
15. Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation. Ueno T; Ohta T; Sugio Y; Ohno Y; Uehara Y Bone Marrow Transplant; 2022 May; 57(5):840-842. PubMed ID: 35273388 [No Abstract] [Full Text] [Related]
17. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. Kim HW; Jenista ER; Wendell DC; Azevedo CF; Campbell MJ; Darty SN; Parker MA; Kim RJ JAMA Cardiol; 2021 Oct; 6(10):1196-1201. PubMed ID: 34185046 [TBL] [Abstract][Full Text] [Related]
18. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data. Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939 [TBL] [Abstract][Full Text] [Related]